NXTC

NextCure, Inc.

NextCure, Inc. (NXTC) has 2 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 3, 2026.

The most active filer is 10% Owner ADAR1 Capital Management, LLC with 5 filings. Insiders have net bought $1.6M over the trailing 6 months. The largest single insider purchase in this window was $1.3M by 10% Owner ADAR1 Capital Management, LLC on Jul 30, 2026.

  • Industry:Biotechnology
  • CEO:Michael S. Richman
  • Employees:40
  • HQ:Beltsville, MD, US
  • IPO:2019-05-09

Insider Buying

$1.6M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$15.0M

latest known value

Source
Purchase$1.3MAug 3SEC ↗
Purchase$179KAug 3SEC ↗
Purchase$39KJul 29SEC ↗
Purchase$32KJul 29SEC ↗
Purchase$17KJul 29SEC ↗

Related companies

NextCure, Inc. is in the Healthcare sector.